CDH12 and the development of the neuronal subtype in MIBC. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results